UBS Group’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$388K Sell
5,000
-45,000
-90% -$3.72M ﹤0.01% 6322
2026
Q2
$4.23M Hold
50,000
– – ﹤0.01% 4346
2026
Q1
$4.19M Buy
+50,000
New +$3.77M ﹤0.01% 4253
2021
Q3
– Sell
-4,000
Closed -$177K – 9613
2021
Q2
$177K Hold
4,000
– – ﹤0.01% 5447
2021
Q1
$186K Buy
4,000
+3,968
+12,400% +$176K ﹤0.01% 5539
2020
Q4
$1K Sell
32
-22,426
-100% -$801K ﹤0.01% 8205
2020
Q3
$647K Buy
22,458
+95
+0.4% +$2.68K ﹤0.01% 3972
2020
Q2
$599K Sell
22,363
-2,030
-8% -$52.8K ﹤0.01% 3991
2020
Q1
$573K Buy
24,393
+11,920
+96% +$328K ﹤0.01% 3831
2019
Q4
$369K Buy
12,473
+2,198
+21% +$58.2K ﹤0.01% 5105
2019
Q3
$288K Buy
10,275
+1,738
+20% +$50.2K ﹤0.01% 4973
2019
Q2
$252K Buy
+8,537
New +$230K ﹤0.01% 4768

Other funds holding CTVA

UBS Group's CTVA Position: Q3 2026 in Review

UBS Group increased its Corteva (CTVA) stake by 26% in Q3 2026, buying an estimated $61M and bringing the position to 3,599,241 shares worth $279M. The position accounts for 0.04% of the portfolio, ranked #488.

UBS Group first reported a position in CTVA in Q2 2019 and has held it in 30 quarters since. 1,250 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • UBS Group held 3,599,241 shares of Corteva worth $279M as of Q3 2026.
  • UBS Group bought 737,295 Corteva shares in Q3 2026, an estimated $61M.
  • Corteva made up 0.04% of UBS Group's portfolio in Q3 2026, its #488 holding.
  • UBS Group first reported a position in Corteva in Q2 2019 and has held it in 30 quarters since.
  • 1,250 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.